ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research

August 5, 2011

In Brief: GSA Sitting On Breast Cancer Tapes; Creech, Owens Names President-Elect Of AACR, ASCO

May 27, 1977

Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon

March 1, 2013

Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief

January 15, 1982

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Pilot Study Tests Novel “Metronomic” Delivery

December 30, 2005